药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etorphine
Triptolide
The serum concentration of Triptolide can be decreased when it is combined with Sarecycline.
Etorphine
Cloprostenol
The serum concentration of Cloprostenol can be decreased when it is combined with Sarecycline.
Etorphine
Isosorbide
The serum concentration of Isosorbide can be decreased when it is combined with Sarecycline.
Etorphine
Ulipristal
The serum concentration of Ulipristal can be decreased when it is combined with Sarecycline.
Etorphine
Lonidamine
The serum concentration of Lonidamine can be decreased when it is combined with Sarecycline.
Etorphine
Trestolone
The serum concentration of Trestolone can be decreased when it is combined with Sarecycline.
Etorphine
Octylphenoxy polyethoxyethanol
The serum concentration of Octylphenoxy polyethoxyethanol can be decreased when it is combined with Sarecycline.
Etorphine
p-Coumaric acid
The serum concentration of p-Coumaric acid can be decreased when it is combined with Sarecycline.
Etorphine
Motretinide
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Motretinide is combined with Sarecycline.
Etorphine
Zuretinol acetate
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Zuretinol acetate is combined with Sarecycline.
Etorphine
Ro 12-7310
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Ro 12-7310 is combined with Sarecycline.
Etorphine
Fenretinide
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Fenretinide is combined with Sarecycline.
Etorphine
4-Oxoretinol
The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when 4-Oxoretinol is combined with Sarecycline.
Etorphine
L-tartaric acid
The therapeutic efficacy of Sarecycline can be decreased when used in combination with L-tartaric acid.
Etorphine
Potassium citrate
The therapeutic efficacy of Sarecycline can be decreased when used in combination with Potassium citrate.
Etorphine
(S)-Warfarin
The risk or severity of bleeding can be increased when Sarecycline is combined with (S)-Warfarin.
Etorphine
Tioclomarol
The risk or severity of bleeding can be increased when Sarecycline is combined with Tioclomarol.
Etorphine
Diphenadione
The risk or severity of bleeding can be increased when Sarecycline is combined with Diphenadione.
Etorphine
Clorindione
The risk or severity of bleeding can be increased when Sarecycline is combined with Clorindione.
Etorphine
Fluindione
The risk or severity of bleeding can be increased when Sarecycline is combined with Fluindione.